Gating Mechanism for Biased Agonism at Angiotensin II Type 1 Receptors

For the interaction of angiotensin II (AngII) with AngII type 1 receptors (AT<sub>1</sub>R), two potential proton hopping pathways have been identified, each associated with distinct physiological outcomes. The octapeptide AngII (Asp<sup>1</sup>-Arg<sup>2</sup>-Va...

Full description

Saved in:
Bibliographic Details
Main Authors: Graham J. Moore, Harry Ridgway, Laura Kate Gadanec, Vasso Apostolopoulos, Anthony Zulli, John M. Matsoukas
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/30/11/2399
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:For the interaction of angiotensin II (AngII) with AngII type 1 receptors (AT<sub>1</sub>R), two potential proton hopping pathways have been identified, each associated with distinct physiological outcomes. The octapeptide AngII (Asp<sup>1</sup>-Arg<sup>2</sup>-Val<sup>3</sup>-Tyr<sup>4</sup>-Ile<sup>5</sup>-His<sup>6</sup>-Pro<sup>7</sup>-Phe<sup>8</sup>) appears to form a charge relay system (CRS) in solution in which the C-terminal carboxylate abstracts a proton from the His<sup>6</sup> imidazole group, which, in turn, abstracts a proton from the Tyr<sup>4</sup> hydroxyl (OH) group, creating a tyrosinate anion. When AngII binds to the AT<sub>1</sub>R, the CRS can be reconstituted with D281 of the receptor taking up the role of the Phe<sup>8</sup> carboxylate in the tripartite interaction, whilst the Phe<sup>8</sup> carboxylate forms a salt bridge with K199 of the receptor. As a consequence, the Tyr<sup>4</sup> OH of AngII is positioned with accessibility to either the Phe<sup>8</sup> carboxylate (bound to K199) or the His<sup>6</sup> imidazole (activated by D281), thereby creating a potential gating mechanism for AT<sub>1</sub>R receptor signaling. This study summarizes evidence based on structure activity data for various analogs wherein Tyr<sup>4</sup> OH interaction with His<sup>6</sup> imidazole (CRS formation) leads to G protein sequestration and vasoconstriction, whereas Tyr<sup>4</sup> OH interaction with Phe<sup>8</sup> carboxylate (bound to K199) engenders arrestin-mediated vasodilation and receptor desensitization. These findings, combined with quantum mechanical (semiempirical) calculations of CRS proton transfer presented herein, provide insights for the therapeutic targeting of angiotensin receptor blockers (sartans) and the development of second-generation drugs (bisartans).
ISSN:1420-3049